- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02989337
Endothelial Dysfunction in Hyperemesis Gravidarum
Study Overview
Status
Conditions
Detailed Description
The study population consisted of 2 groups; (1) the hyperemesis gravidarum group, consist of 25 pregnant women who developed dehydration due to HG between 6 and 13 gestational weeks and between 18 and 35 years (2) the normal pregnancy group, consisting of 25 pregnant women.
HG was defined according to the fallowing American College of Obstetricians and Gynecologists (ACOG) criteria; severe nausea and vomiting resulted in 5% weight loss with regard to pre-gestation or vomiting more than 3 times and 3-5 % weight loss with ketonuria. The diagnosis of dehydration was clinically defined and patients with moderate and severe dehydration were included in the study. As clinical findings; Weight loss, capillary recall time, dry mucous membranes, dry eye, pulse rate, systolic blood pressure, respiration, skin turgor deterioration and urine output were evaluated.
Other pathologies causing nausea and vomiting like; gastroenteritis, gastroparesis, gall duct diseases, hepatitis, peptic ulcers, appendicitis, pyelonephritis, ovarian torsion, urinary tract stones, diabetic ketoacidosis, hyperthyroidism, hyperparathyroidism, migraine, pseudo tumor cerebra, vestibular diseases were excluded from the study.Patients were excluded from the study in the presence of pregestational diabetes chronic hypertension, chronic liver and renal failure, preeclampsia history, multiple pregnancy, hyperlipidemia, hypercholesterolemia, obesity, tobacco use, NSAID drug use, infection within the last three months and surgery within the last month that could cause endothelial dysfunction.
Blood and urine specimens were collected from the patients with HG during hospitalization and during regular clinic visits in control group. The 2mL of blood samples were withdrawn into serum-separating tubes for the measurements of serum biochemical parameters and 2 mL blood samples were withdrawn into EDTA containing tubes for measurement serum hemoglobin and hematocrit levels. Early-morning urine samples were collected from study population. These blood and urine samples were analyzed in same day for Kayseri Education and Research hospital biochemical clinics. In addition 2mL of blood samples were withdrawn into serum-separating tubes for analyzing serum sVEGFR-1, sVCAM-1, sE-selectin and sICAM-1 levels. All of the serum were stored at -80°C in nonadsorbable tubes. After three months for stored first blood sample, serum sVEGFR-1, sVCAM-1, sE-selectin and sICAM-1 levels were determined by an enzyme linked immunosorbent assay.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Yusuf MADENDAG, Central Contact Backup
- Phone Number: +905055011340
- Email: yusufmadendag@gmail.com
Study Locations
-
-
-
Kayseri, Turkey, 38000
- Recruiting
- Kayseri Training and Research Hospital
-
Contact:
- yusuf madendag
- Phone Number: +905055011340
- Email: yusufmadedag@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- 6-13 gestational weeks
- between 18-35 years of age
- Single pregnancy
- Dehydration due to HG
Exclusion Criteria:
Other pathologies causing nausea and vomiting;
- gastroenteritis
- gastroparesis
- gall duct diseases
- hepatitis
- peptic ulcers
- appendicitis
- pyelonephritis
- urinary tract stones
- hyperthyroidism
- hyperparathyroidism
- migraine
- vestibular diseases
Patients were excluded from the study in the presence of parameters that may cause endothelial dysfunction such as;
- pregestational diabetes
- chronic hypertension
- chronic liver and renal failure
- preeclampsia history
- multiple pregnancy
- hyperlipidemia
- hypercholesterolemia
- obesity
- tobacco use
- NSAID drug use
- infection within the last three months
- surgery within the last month
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
hyperemesis gravidarum with dehydration
The first group was formed of the patients diagnosed hyperemesis gravidarum with dehydration
|
Control group
The control group was formed of the patients who were healthy pregnant women admitted to the clinic just for routine examination without any symptoms
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Serum inflammatory adhesion molecules in hyperemesis gravidarum
Time Frame: 4 months
|
4 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016/579
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hyperemesis; Gravidarum, With Dehydration
-
Kayseri Education and Research HospitalCompletedGestational Diabetes | Hyperemesis; Gravidarum, With Dehydration
-
University of VirginiaRecruitingCannabinoid Hyperemesis SyndromeUnited States
-
University of CalgaryCanadian Institutes of Health Research (CIHR)Completed
-
Kayseri Education and Research HospitalUnknown
-
Mercy Health OhioLake Erie College of Osteopathic MedicineRecruitingCannabis Hyperemesis SyndromeUnited States
-
Nordsjaellands HospitalOdense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Hvidovre University Hospital and other collaboratorsTerminatedHyperemesis Gravidarum | Nausea Gravidarum | Vomiting of PregnancyDenmark
-
Batman Training and Research HospitalCompletedCorneal Dystrophy | Macular Dystrophy | Hyperemesis Gravidarum - SevereTurkey
-
State University of New York at BuffaloEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedHyperemesis GravidarumUnited States
-
Azienda Ospedaliera Città della Salute e della...CompletedHyperemesis GravidarumItaly
-
Tasnem Abo-elouonAssiut UniversityCompletedHyperemesis GravidarumEgypt